ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
The successful candidate will join the Kornfeld group to investigate how learned behaviours are encoded in the brain’s synaptic networks. The role will involve conducting high-resolution 3D electron microscopy and expansion microscopy experiments to map the synaptic connections in various model organisms. You will be responsible for tissue preparation, imaging, and data acquisition, followed by the detailed analysis of these vast datasets.
We're looking for a Scientific Editor to join our Data and Community Function, helping to curate, enhance, and promote the world-renowned Cambridge Structural Database (CSD), a critical resource used by scientists across academia and industry worldwide.
This is a unique opportunity to play a key role in maintaining the quality and integrity of structural chemistry data while contributing to scientific training, outreach, and education initiatives that support the global research community.
About the Role
Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle® molecules attractive candidates for drug development.
How are organizations architecting functional Artificial Intelligence (AI) strategies that will shape the next phase of AI in Medical Affairs?
Earlier this year, Digital Science brought together Medical Affairs leaders to explore how they’re approaching AI, and why they need to embed sustainable AI capabilities in day-to-day workflows.
The conversation covered six key topics:
About NIHR BioResource:
Our mission is to facilitate human health research and its transformation into medical practice.
NIHR BioResource is a unique and powerful resource for studying disease mechanisms and for investigating the links between genes, the environment, health and disease, enabling scientific discoveries as well as facilitating translational medicine for the benefit of patients.
We’re looking for an ambitious and collaborative Group Leader (Professor or Associate Professor equivalent) or Career Track Group Leader (Assistant Professor equivalent) to establish an independent research programme focused on advancing our understanding of how food and food components influence the human gut microbiome and host health.
The role:
The Policy and Public Affairs Manager will work with the Head of Strategic Engagement to deliver a framework of policy and public affairs activities as outlined in the John Innes Centre’s Engagement Strategy. The role will ensure that the JIC has clear routes to provide evidence to inform and influence priority areas of policy and that staff and students across the JIC are effectively supported to successfully engage with policy makers.
AI is changing how quickly we can produce work. But what is research telling us about how it is changing about the way teams work together and what we need to lead well?
Most organisations are focused on choosing the right AI tools and putting the right governance in place. Fewer are asking what AI means for trust, leadership and how people learn and make decisions together.